Detalhe da pesquisa
1.
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers.
Br J Cancer
; 117(4): 494-502, 2017 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28664915
2.
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: implications for personalized cancer therapy.
Proteomics
; 15(2-3): 365-73, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25311472